Institut de Chimie Moléculaire de l'Université de Bourgogne, ICMUB CNRS UMR 6302, UBFC Dijon, France.
Institut de Chimie Moléculaire de l'Université de Bourgogne, ICMUB CNRS UMR 6302, UBFC Dijon, France.
Cell Chem Biol. 2021 Apr 15;28(4):436-455. doi: 10.1016/j.chembiol.2021.01.015. Epub 2021 Feb 16.
For over two decades, the prime objective of the chemical biology community studying G-quadruplexes (G4s) has been to use chemicals to interact with and stabilize G4s in cells to obtain mechanistic interpretations. This strategy has been undoubtedly successful, as demonstrated by recent advances. However, these insights have also led to a fundamental rethinking of G4-targeting strategies: due to the prevalence of G4s in the human genome, transcriptome, and ncRNAome (collectively referred to as the G4ome), and their involvement in human diseases, should we continue developing G4-stabilizing ligands or should we invest in designing molecular tools to unfold G4s? Here, we first focus on how, when, and where G4s fold in cells; then, we describe the enzymatic systems that have evolved to counteract G4 folding and how they have been used as tools to manipulate G4s in cells; finally, we present strategies currently being implemented to devise new molecular G4 unwinding agents.
二十多年来,研究 G-四链体 (G4s) 的化学生物学领域的主要目标一直是使用化学物质与细胞中的 G4 相互作用并稳定 G4,以获得机制解释。这一策略无疑是成功的,最近的进展也证明了这一点。然而,这些发现也导致了对 G4 靶向策略的根本性重新思考:由于 G4 在人类基因组、转录组和 ncRNA 组(统称为 G4ome)中的普遍性,以及它们在人类疾病中的参与,我们是否应该继续开发 G4 稳定配体,还是应该投资设计分子工具来展开 G4?在这里,我们首先关注 G4s 在细胞中何时、何地以及如何折叠;然后,我们描述了已经进化出的对抗 G4 折叠的酶系统,以及它们如何被用作在细胞中操纵 G4 的工具;最后,我们提出了目前正在实施的策略,以设计新的分子 G4 解旋剂。